Literature DB >> 8624874

Amiodarone in congestive heart failure: unravelling the GESICA and CHF-STAT differences.

S C Hammill, D L Packer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8624874      PMCID： PMC484212          DOI： 10.1136/hrt.75.1.6

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  9 in total

1.  Mortality in heart failure: clinical variables of prognostic value.

Authors:  J G Cleland; H J Dargie; I Ford
Journal:  Br Heart J       Date:  1987-12

2.  Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

Authors:  F Burkart; M Pfisterer; W Kiowski; F Follath; D Burckhardt
Journal:  J Am Coll Cardiol       Date:  1990-12       Impact factor: 24.094

3.  Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy.

Authors:  J M Nicklas; W J McKenna; R A Stewart; J K Mickelson; S K Das; M A Schork; S J Krikler; L A Quain; F Morady; B Pitt
Journal:  Am Heart J       Date:  1991-10       Impact factor: 4.749

4.  Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study.

Authors:  L Ceremuzynski; E Kleczar; M Krzeminska-Pakula; J Kuch; E Nartowicz; J Smielak-Korombel; A Dyduszynski; J Maciejewicz; T Zaleska; E Lazarczyk-Kedzia
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

5.  Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study.

Authors:  J A Cairns; S J Connolly; M Gent; R Roberts
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

6.  Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

Authors:  H C Doval; D R Nul; H O Grancelli; S V Perrone; G R Bortman; R Curiel
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

7.  Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.

Authors:  R Neri; L Mestroni; A Salvi; C Pandullo; F Camerini
Journal:  Am Heart J       Date:  1987-03       Impact factor: 4.749

8.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

Review 9.  Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia.

Authors:  S H Hohnloser; T Klingenheben; B N Singh
Journal:  Ann Intern Med       Date:  1994-10-01       Impact factor: 25.391
  9 in total
  2 in total

Review 1.  Optimal treatment of heart failure in the elderly.

Authors:  R Doughty; V Andersen; N Sharpe
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

Review 2.  Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.

Authors:  C M Newman; A Price; D W Davies; T A Gray; A P Weetman
Journal:  Heart       Date:  1998-02       Impact factor: 5.994
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.